ARK Genomic Revolution ETF (BATS:ARKG) Shares Sold by Clearwater Capital Advisors LLC

Clearwater Capital Advisors LLC cut its holdings in ARK Genomic Revolution ETF (BATS:ARKG) by 0.6% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 172,661 shares of the company’s stock after selling 1,098 shares during the quarter. Clearwater Capital Advisors LLC owned 0.31% of ARK Genomic Revolution ETF worth $4,054,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Principal Securities Inc. acquired a new stake in ARK Genomic Revolution ETF in the 4th quarter worth about $32,000. Chris Bulman Inc acquired a new stake in ARK Genomic Revolution ETF during the 2nd quarter worth $36,000. Northwest Financial Advisors acquired a new stake in shares of ARK Genomic Revolution ETF in the fourth quarter valued at about $47,000. Tidemark LLC acquired a new stake in shares of ARK Genomic Revolution ETF in the fourth quarter valued at about $48,000. Finally, EverSource Wealth Advisors LLC purchased a new position in shares of ARK Genomic Revolution ETF in the first quarter worth about $49,000.

ARK Genomic Revolution ETF Trading Down 2.9 %

ARKG traded down $0.73 on Friday, reaching $24.24. 2,388,577 shares of the company’s stock were exchanged. The business has a fifty day moving average price of $25.38 and a two-hundred day moving average price of $26.17.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.